Experimental Alzheimer’s Immunotherapy Shows Early Promise in Mice

Significant obstacles remain before potential human therapy.

Robert Kneschke/Shutterstock

Immunotherapy could hold promising results for treating Alzheimer’s disease as well as other neurological disorders.

The therapy aims to harness the power of the immune system to remove harmful proteins in the brain associated with conditions like Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS), according to new study published in Science Translational Medicine.

Using Brain Cells to Target Plaques and Tangles

Typically used for cancer treatment, immunotherapy works by harnessing the body’s immune system to recognize and attack harmful cells.